Literature DB >> 19031289

NeuroAIDS in the Asia Pacific Region.

Edwina J Wright1, Michael Nunn, Jeymohan Joseph, Kevin Robertson, Luxshimi Lal, Bruce J Brew.   

Abstract

Over 8.3 million people living in the Asia Pacific region are human immunodeficiency virus (HIV) positive and up to 40% of these individuals have had prior acquired immunodeficiency syndrome (AIDS) illnesses. Recently endeavors have been made to better characterize the burden of HIV-related neurological disease within the Asia Pacific region and, with this in mind, the NeuroAIDS in Asia and the Pacific Rim workshop was held in Sydney, Australia, as an affiliated event of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention. The workshop was supported by the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Mental Health (NIMH) of the United States National Institutes of Health and the Australian Government overseas AID program, AusAID. HIV neurologists, infectious disease physicians, pediatricians, psychiatrists, immunologists, virologists,and researchers from 12 countries of the Asia Pacific region (including Australia), the United States, and the United Kingdom attended the meeting. A broad range of topics were addressed, including common HIV neurological disorders, the lack of diagnostic, management, and research infrastructure, central nervous system (CNS) immune restoration disease, pediatric neuroAIDS, and current clinical and laboratory research projects being undertaken within the Asia Pacific region.

Entities:  

Mesh:

Year:  2008        PMID: 19031289     DOI: 10.1080/13550280802235932

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  38 in total

1.  Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

Authors:  David W Haas; Heather J Ribaudo; Richard B Kim; Camlin Tierney; Grant R Wilkinson; Roy M Gulick; David B Clifford; Todd Hulgan; Catia Marzolini; Edward P Acosta
Journal:  AIDS       Date:  2004-12-03       Impact factor: 4.177

Review 2.  The subtypes of human immunodeficiency virus in Australia and Asia.

Authors:  Robert Oelrichs
Journal:  Sex Health       Date:  2004       Impact factor: 2.706

Review 3.  Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis.

Authors:  Melanie Walker; James G Kublin; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2005-11-23       Impact factor: 9.079

4.  CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.

Authors:  Matthew J Dolan; Hemant Kulkarni; Jose F Camargo; Weijing He; Alison Smith; Juan-Manuel Anaya; Toshiyuki Miura; Frederick M Hecht; Manju Mamtani; Florencia Pereyra; Vincent Marconi; Andrea Mangano; Luisa Sen; Rosa Bologna; Robert A Clark; Stephanie A Anderson; Judith Delmar; Robert J O'Connell; Andrew Lloyd; Jeffrey Martin; Seema S Ahuja; Brian K Agan; Bruce D Walker; Steven G Deeks; Sunil K Ahuja
Journal:  Nat Immunol       Date:  2007-10-21       Impact factor: 25.606

Review 5.  Over-diagnosis and co-morbidity of severe malaria in African children: a guide for clinicians.

Authors:  Samson Gwer; Charles R J C Newton; James A Berkley
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

6.  Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif.

Authors:  Mamata Mishra; S Vetrivel; Nagadenahalli B Siddappa; Udaykumar Ranga; Pankaj Seth
Journal:  Ann Neurol       Date:  2008-03       Impact factor: 10.422

7.  Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 *6 and *26.

Authors:  Hiroyuki Gatanaga; Tsunefusa Hayashida; Kiyoto Tsuchiya; Munehiro Yoshino; Takeshi Kuwahara; Hiroki Tsukada; Katsuya Fujimoto; Isao Sato; Mikio Ueda; Masahide Horiba; Motohiro Hamaguchi; Masahiro Yamamoto; Noboru Takata; Akiro Kimura; Takao Koike; Fumitake Gejyo; Shuzo Matsushita; Takuma Shirasaka; Satoshi Kimura; Shinichi Oka
Journal:  Clin Infect Dis       Date:  2007-09-24       Impact factor: 9.079

8.  HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa.

Authors:  Kate Grimwade; Neil French; Daniel D Mbatha; Dawn D Zungu; Martin Dedicoat; Charles F Gilks
Journal:  AIDS       Date:  2004-02-20       Impact factor: 4.177

9.  Class of antiretroviral drugs and the risk of myocardial infarction.

Authors:  Nina Friis-Møller; Peter Reiss; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa El-Sadr; Rodolphe Thiébaut; Stephane De Wit; Ole Kirk; Eric Fontas; Matthew G Law; Andrew Phillips; Jens D Lundgren
Journal:  N Engl J Med       Date:  2007-04-26       Impact factor: 91.245

10.  Detection of HIV seropositivity during an outbreak of Japanese encephalitis in Manipur.

Authors:  D K Neogi; N Bhattacharya; T Chakrabarti; K K Mukherjee
Journal:  J Commun Dis       Date:  1998-06
View more
  7 in total

1.  Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study.

Authors:  K Robertson; H Jiang; J Kumwenda; K Supparatpinyo; S Evans; T B Campbell; R Price; S Tripathy; N Kumarasamy; A La Rosa; B Santos; M T Silva; S Montano; C Kanyama; S Faesen; R Murphy; C Hall; C M Marra; C Marcus; B Berzins; R Allen; M Housseinipour; F Amod; I Sanne; J Hakim; A Walawander; A Nair
Journal:  Clin Infect Dis       Date:  2012-06-01       Impact factor: 9.079

Review 2.  Antiretroviral therapy improves neurocognitive impairment in people living with HIV? A meta-analysis.

Authors:  Chang Gao; Jingjing Meng; Xueling Xiao; Min Wang; Ann Barterley Williams; Honghong Wang
Journal:  Int J Nurs Sci       Date:  2020-03-23

3.  Evaluating sleep and cognition in HIV.

Authors:  Charlene E Gamaldo; Alyssa Gamaldo; Jason Creighton; Rachel E Salas; Ola A Selnes; Paula M David; Gilbert Mbeo; Benjamin S Parker; Amanda Brown; Justin C McArthur; Michael T Smith
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-15       Impact factor: 3.731

Review 4.  Controversies in HIV-associated neurocognitive disorders.

Authors:  Sam Nightingale; Alan Winston; Scott Letendre; Benedict D Michael; Justin C McArthur; Saye Khoo; Tom Solomon
Journal:  Lancet Neurol       Date:  2014-11       Impact factor: 44.182

5.  Intercellular Adhesion Molecular-5 as Marker in HIV Associated Neurocognitive Disorder.

Authors:  Lin Yuan; Feili Wei; Xin Zhang; Xianghua Guo; Xiaofan Lu; Bin Su; Tong Zhang; Hao Wu; Dexi Chen
Journal:  Aging Dis       Date:  2017-05-02       Impact factor: 6.745

Review 6.  HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment.

Authors:  Antonia Carroll; Bruce Brew
Journal:  F1000Res       Date:  2017-03-23

Review 7.  Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury.

Authors:  Nina Y Yuan; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-06       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.